Second Near-Infrared Light-Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer Therapy.


Journal

Advanced materials (Deerfield Beach, Fla.)
ISSN: 1521-4095
Titre abrégé: Adv Mater
Pays: Germany
ID NLM: 9885358

Informations de publication

Date de publication:
Sep 2021
Historique:
revised: 27 04 2021
received: 19 02 2021
pubmed: 24 7 2021
medline: 19 1 2022
entrez: 23 7 2021
Statut: ppublish

Résumé

Immunometabolic modulation offers new opportunities to treat cancers as it is highly associated with cancer progression and immunosuppressive microenvironment. However, traditional regimens using nonselective small-molecule immunomodulators lead to the off-target adverse effects and insufficient therapeutic outcomes. Herein a second near-infrared (NIR-II) photothermally activatable semiconducting polymeric nanoantagonist (ASPA) for synergistic photothermal immunometabolic therapy of cancer is reported. ASPA backbone is obtained by conjugating vipadenant, an antagonist to adenosine A2A receptor, onto NIR-II light-absorbing semiconducting polymer via an azo-based thermolabile linker. Under deep-penetrating NIR-II photoirradiation, ASPA induces tumor thermal ablation and subsequently immunogenic cell death, triggers the cleavage of thermolabile linker, and releases the antagonist to block the immunosuppressive adenosinergic pathway. Such a remotely controlled immunometabolic regulation potentiates cytotoxic T cell functions while suppresses regulatory T cell activities, leading to efficient primary tumor inhibition, pulmonary metastasis prevention, and long-term immunological memory. Thereby, this work provides a generic polymeric approach for precise spatiotemporal regulation of cancer immunometabolism.

Identifiants

pubmed: 34296785
doi: 10.1002/adma.202101410
doi:

Substances chimiques

Polymers 0
Caspase 3 EC 3.4.22.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2101410

Subventions

Organisme : Ministry of Education, Academic Research Fund Tier 1
ID : 2019-T1-002-045
Organisme : Ministry of Education, Academic Research Fund Tier 1
ID : RG125/19
Organisme : Academic Research Fund Tier 2
ID : MOE2018-T2-2-042
Organisme : A*STAR SERC AME Programmatic Fund
ID : SERC A18A8b0059

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

J. Nam, S. Son, K. S. Park, W. Zou, L. D. Shea, J. J. Moon, Nat. Rev. Mater. 2019, 4, 398.
a) Z. Hu, P. A. Ott, C. J. Wu, Nat. Rev. Immunol. 2018, 18, 168;
b) B. Ding, S. Shao, C. Yu, B. Teng, M. Wang, Z. Cheng, K. L. Wong, P. a. Ma, J. Lin, Adv. Mater. 2018, 30, 1802479;
c) Y. Yin, X. Li, H. Ma, J. Zhang, D. Yu, R. Zhao, S. Yu, G. Nie, H. Wang, Nano Lett. 2021, 21, 2224.
a) S. A. Rosenberg, N. P. Restifo, Science 2015, 348, 62;
b) L. Tang, Y. Zheng, M. B. Melo, L. Mabardi, A. P. Castaño, Y.-Q. Xie, N. Li, S. B. Kudchodkar, H. C. Wong, E. K. Jeng, Nat. Biotechnol. 2018, 36, 707;
c) X. Xu, T. Li, S. Shen, J. Wang, P. Abdou, Z. Gu, R. Mo, Theranostics 2019, 9, 7889.
a) F. Martins, L. Sofiya, G. P. Sykiotis, F. Lamine, M. Maillard, M. Fraga, K. Shabafrouz, C. Ribi, A. Cairoli, Y. Guex-Crosier, Nat. Rev. Clin. Oncol. 2019, 16, 563;
b) X. Duan, C. Chan, N. Guo, W. Han, R. R. Weichselbaum, W. Lin, J. Am. Chem. Soc. 2016, 138, 16686;
c) C. Wang, Y. Ye, G. M. Hochu, H. Sadeghifar, Z. Gu, Nano Lett. 2016, 16, 2334;
d) J. J. Havel, D. Chowell, T. A. Chan, Nat. Rev. Cancer 2019, 19, 133.
a) C. Mazumdar, E. M. Driggers, L. A. Turka, Cell Metab. 2020, 31, 26;
b) X. Li, M. Wenes, P. Romero, S. C.-C. Huang, S.-M. Fendt, P.-C. Ho, Nat. Rev. Clin. Oncol. 2019, 16, 425;
c) G. J. Koelwyn, X. Zhuang, T. Tammela, A. Schietinger, L. W. Jones, Nat. Metab. 2020, 2, 849.
A. Brand, K. Singer, G. E. Koehl, M. Kolitzus, G. Schoenhammer, A. Thiel, C. Matos, C. Bruss, S. Klobuch, K. Peter, Cell Metab. 2016, 24, 657.
a) Y. Liu, X. Liang, X. Yin, J. Lv, K. Tang, J. Ma, T. Ji, H. Zhang, W. Dong, X. Jin, Nat. Commun. 2017, 8, 15207;
b) H. Huang, C.-T. Jiang, S. Shen, A. Liu, Y.-J. Gan, Q.-S. Tong, S.-B. Chen, Z.-X. Gao, J.-Z. Du, J. Cao, Nano Lett. 2019, 19, 5356.
D. Vijayan, A. Young, M. W. Teng, M. J. Smyth, Nat. Rev. Cancer 2017, 17, 709.
L. Fong, A. Hotson, J. D. Powderly, M. Sznol, R. S. Heist, T. K. Choueiri, S. George, B. G. Hughes, M. D. Hellmann, D. R. Shepard, Cancer Discovery 2020, 10, 40.
K. Esfahani, A. Elkrief, C. Calabrese, R. Lapointe, M. Hudson, B. Routy, W. H. Miller, L. Calabrese, Nat. Rev. Clin. Oncol. 2020, 17, 504.
L. P. Andrews, H. Yano, D. A. Vignali, Nat. Immunol. 2019, 20, 1425.
a) W. Jiang, Y. Wang, J. A. Wargo, F. F. Lang, B. Y. Kim, Nat. Nanotechnol. 2020, 16, 6;
b) C. Xu, Y. Jiang, Y. Han, K. Pu, R. Zhang, Adv. Mater. 2021, 33, 2008061.
a) H. Deng, Z. Zhou, W. Yang, L.-s. Lin, S. Wang, G. Niu, J. Song, X. Chen, Nano Lett. 2020, 20, 1928;
b) C. Xu, S. Yang, Z. Jiang, J. Zhou, J. Yao, Nano Lett. 2019, 20, 372;
c) B. Bockorny, V. Semenisty, T. Macarulla, E. Borazanci, B. M. Wolpin, S. M. Stemmer, T. Golan, R. Geva, M. J. Borad, K. S. Pedersen, Nat. Med. 2020, 26, 878.
a) S. Gao, T. Li, Y. Guo, C. Sun, B. Xianyu, H. Xu, Adv. Mater. 2020, 32, 1907568;
b) K. Lu, C. He, N. Guo, C. Chan, K. Ni, G. Lan, H. Tang, C. Pelizzari, Y.-X. Fu, M. T. Spiotto, Nat. Biomed. Eng. 2018, 2, 600.
Z. Zeng, C. Zhang, J. Li, D. Cui, Y. Jiang, K. Pu, Adv. Mater. 2020, 33, 2007247.
a) D. Cui, J. Huang, X. Zhen, J. Li, Y. Jiang, K. Pu, Angew. Chem., Int. Ed. 2019, 58, 5920;
b) Y. Yuan, J. Zhang, X. Qi, S. Li, G. Liu, S. Siddhanta, I. Barman, X. Song, M. T. McMahon, J. W. Bulte, Nat. Mater. 2019, 18, 1376;
c) Z. Wang, X. Zhen, P. K. Upputuri, Y. Jiang, J. Lau, M. Pramanik, K. Pu, B. Xing, ACS Nano 2019, 13, 5816;
d) Y. Yu, C. Xu, L. Zhen, S. Yang, J. Zhou, J. Yao, Carbohydr. Polym. 2019, 220, 30;
e) P. Zhang, J. Wang, H. Chen, L. Zhao, B. Chen, C. Chu, H. Liu, Z. Qin, J. Liu, Y. Tan, J. Am. Chem. Soc. 2018, 140, 14980;
f) J. Mu, J. Lin, P. Huang, X. Chen, Chem. Soc. Rev. 2018, 47, 5554.
a) Y. Zhang, C. Xu, X. Yang, K. Pu, Adv. Mater. 2020, 32, 2002661;
b) C. Zhang, K. Pu, Chem. Soc. Rev. 2020, 49, 4234;
c) S. Ma, W. Song, Y. Xu, X. Si, S. Lv, Y. Zhang, Z. Tang, X. Chen, Nano Lett. 2020, 20, 2514;
d) S. Shen, L. Feng, S. Qi, J. Cao, Y. Ge, L. Wu, S. Wang, Nano Lett. 2020, 20, 2137.
Y. Jiang, J. Huang, C. Xu, K. Pu, Nat. Commun. 2021, 12, 742.
X. Han, K. Cheng, Y. Xu, Y. Wang, H. Min, Y. Zhang, X. Zhao, R. Zhao, G. J. Anderson, L. Ren, J. Am. Chem. Soc. 2020, 142, 2490.
H. Chu, J. Zhao, Y. Mi, Z. Di, L. Li, Nat. Commun. 2019, 10, 2839.
a) C. Xu, K. Pu, Chem. Soc. Rev. 2021, 50, 1111;
b) X. Li, J. F. Lovell, J. Yoon, X. Chen, Nat. Rev. Clin. Oncol. 2020, 17, 657.
H. Liu, C. Li, Y. Qian, L. Hu, J. Fang, W. Tong, R. Nie, Q. Chen, H. Wang, Biomaterials 2020, 232, 119700.
a) H. Lin, S. Gao, C. Dai, Y. Chen, J. Shi, J. Am. Chem. Soc. 2017, 139, 16235;
b) Y. Cao, T. Wu, K. Zhang, X. Meng, W. Dai, D. Wang, H. Dong, X. Zhang, ACS Nano 2019, 13, 1499;
c) C. Zhou, L. Zhang, T. Sun, Y. Zhang, Y. Liu, M. Gong, Z. Xu, M. Du, Y. Liu, G. Liu, Adv. Mater. 2021, 33, 2006532.
S. Li, Q. Deng, Y. Zhang, X. Li, G. Wen, X. Cui, Y. Wan, Y. Huang, J. Chen, Z. Liu, L. Wang, C. S. Lee, Adv. Mater. 2020, 32, 2001146.
a) Z. Zhang, X. Fang, Z. Liu, H. Liu, D. Chen, S. He, J. Zheng, B. Yang, W. Qin, X. Zhang, Angew. Chem., Int. Ed. 2020, 59, 3691;
b) S. Liu, H. Ou, Y. Li, H. Zhang, J. Liu, X. Lu, R. T. Kwok, J. W. Lam, D. Ding, B. Z. Tang, J. Am. Chem. Soc. 2020, 142, 15146.
a) K. Pu, A. J. Shuhendler, J. V. Jokerst, J. Mei, S. S. Gambhir, Z. Bao, J. Rao, Nat. Nanotechnol. 2014, 9, 233;
b) Y. Lyu, C. Xie, S. A. Chechetka, E. Miyako, K. Pu, J. Am. Chem. Soc. 2016, 138, 9049;
c) J. Li, J. Huang, Y. Lyu, J. Huang, Y. Jiang, C. Xie, K. Pu, J. Am. Chem. Soc. 2019, 141, 4073.
X. Chen, Y. Chen, H. Xin, T. Wan, Y. Ping, Proc. Natl. Acad. Sci. U. S. A. 2020, 117, 2395.
Y. Jiang, P. K. Upputuri, C. Xie, Y. Lyu, L. Zhang, Q. Xiong, M. Pramanik, K. Pu, Nano Lett. 2017, 17, 4964.
a) Y. Jiang, X. Zhao, J. Huang, J. Li, P. K. Upputuri, H. Sun, X. Han, M. Pramanik, Y. Miao, H. Duan, K. Pu, Nat. Commun. 2020, 11, 1857;
b) J. Li, X. Yu, Y. Jiang, S. He, Y. Zhang, Y. Luo, K. Pu, Adv. Mater. 2020, 33, 2003458.
a) J. Nam, S. Son, L. J. Ochyl, R. Kuai, A. Schwendeman, J. J. Moon, Nat. Commun. 2018, 9, 1074;
b) Z. Huang, Y. Wang, D. Yao, J. Wu, Y. Hu, A. Yuan, Nat. Commun. 2021, 12, 145.
D. V. Krysko, A. D. Garg, A. Kaczmarek, O. Krysko, P. Agostinis, P. Vandenabeele, Nat. Rev. Cancer 2012, 12, 860.

Auteurs

Cheng Xu (C)

School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore.

Yuyan Jiang (Y)

School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore.

Jingsheng Huang (J)

School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore.

Jiaguo Huang (J)

School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore.

Kanyi Pu (K)

School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore.
Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore, 637371, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH